PEDIATRICS Vol. 97 No. 4 April 1996, pp. 449-455
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolfson, M. R.
Right arrow Articles by Shaffer, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolfson, M. R.
Right arrow Articles by Shaffer, T. H.

Pulmonary Administration of Vasoactive Substances by Perfluorochemical Ventilation

Marla R. Wolfson PhD1, Jay S. Greenspan MD2, and Thomas H. Shaffer PhD1

1 Departments of Physiology and Pediatrics, Temple University School of Medicine, and St Christopher's Hospital for Children, Philadelphia, Pennsylvania
2 Department of Pediatrics, Temple University School of Medicine, and St Christopher's Hospital for Children, Philadelphia, Pennsylvania; Jefferson Medical College, Philadelphia, Pennsylvania

Objectives. Therapeutic management of respiratory distress syndrome, pneumonia, and pulmonary hypertension includes delivery of biologically active agents to the neonatal lung. However, mechanical abnormalities of the lung, intrapulmonary shunting, ventilation-perfusion mismatching, and elevated surface tension impede effective systemic or intratracheal delivery of agents to the lung during conventional gas ventilation. The objective of this study was to test the hypothesis that perfluorochemical (PFC) liquid ventilation can be used for pulmonary administration of vasoactive drugs (PAD) and to compare these responses to those elicited with intravascular (IV) administration during tidal liquid ventilation.

Methods. Cardiovascular responses of 16 preterm and neonatal lambs to randomized doses of acetylcholine, epinephrine, and priscoline were studied. Physiologic gas exchange and acid-base balance were maintained using previously described tidal liquid ventilation techniques. In subgroups of animals, the distribution pattern of carbon 1- and choline 14-labeled dipalmitoylphos-phatidylcholine (14C-DPPC) in saline and the responses to priscoline after hypoxia-induced pulmonary hypertension and hypoxemia administered during liquid ventilation were studied.

Results. Dose-response curves for PAD and IV administration demonstrated progressive, dose-dependent, cholinergic responses to acetylcholine (decreased mean systemic arterial pressure [MAP] and heart rate), sympathomimetic responses to epinephrine (increased MAP and heart rate), and agr-adrenergic blockade responses to priscoline (decreased MAP and mean pulmonary arterial pressure). Compared with IV administration, PAD of priscoline resulted in a significantly greater decrease in pulmonary relative to systemic arterial pressure; this response was potentiated by hypoxia, reduced pulmonary pressures to near normal values, and improved oxygenation. The 14C-DPPC in saline was distributed relatively homogeneously throughout the lung by PAD, with 80% of the lung pieces receiving amounts of 14C-DPPC with ±20% of the mean value.

Conclusions. This study demonstrates that vasoactive agents can be delivered to the lung directly by PAD during PFC liquid ventilation. The inherent advantages of this method relate to the physical properties of PFC liquid ventilation as a vehicle (respiratory gas solublity, low surface tension-enhancing distribution, and inertness precluding interaction) and physiological properties of the lung as an exchanger.

Submitted on September 13, 1995
Accepted on January 2, 1996




This article has been cited by other articles:


Home page
 Br. J. Radiol.Home page
R Tiruvoipati, S K Balasubramanian, J J Entwisle, R K Firmin, and G J Peek
Pseudocalcification on chest CT scan
Br. J. Radiol., July 1, 2007; 80(955): e125 - e127.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
U. Kaisers, K. P. Kelly, and T. Busch
Liquid ventilation
Br. J. Anaesth., July 1, 2003; 91(1): 143 - 151.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. R. FRANZ, W. ROHLKE, R. P. FRANKE, M. EBSEN, F. POHLANDT, and H. D. HUMMLER
Pulmonary Administration of Perfluorodecaline- Gentamicin and Perfluorodecaline- Vancomycin Emulsions
Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1595 - 1600.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. F. Miller, B. Milestone, R. Stern, T. H. Shaffer, and M. R. Wolfson
Effects of perfluorochemical distribution and elimination dynamics on cardiopulmonary function
J Appl Physiol, March 1, 2001; 90(3): 839 - 849.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
K. J Barrington and N. N Finer
Recent advances: care of near term infants with respiratory failure
BMJ, November 8, 1997; 315(7117): 1215 - 1218.
[Full Text]

Home page
 PediatricsHome page
W. W. Fox, C. M. Weis, C. Cox, C. Farina, H. Drott, M. R. Wolfson, and T. H. Shaffer
Pulmonary Administration of Gentamicin During Liquid Ventilation in a Newborn Lamb Lung Injury Model
Pediatrics, November 1, 1997; 100(5): e5 - e5.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. H. Shaffer, R. Foust III, M. R. Wolfson, and T. F. Miller Jr.
Analysis of perfluorochemical elimination from the respiratory system
J Appl Physiol, September 1, 1997; 83(3): 1033 - 1033.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
T. A. Merritt and G. P. Heldt
Partial Liquid Ventilation -- The Future is Now
N. Engl. J. Med., September 12, 1996; 335(11): 814 - 815.
[Full Text]